# Conagra Brands Inc. (CAG) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/CAG/thesis · /stocks/CAG/memo

## Financial Snapshot

---
ticker: CAG
step: 04
title: Financial Quality & Adversarial Sweep
source: coverage-next-full
date: 2026-05-28
---

### Step 04 — Financial Quality & Adversarial Sweep

#### Key Findings
- **Quality of earnings is fair, not great.** FY25 reported EPS of $2.40 [S2] is mathematically clean but benefits from an abnormally low effective tax rate (~0.3%, vs. ~25–26% normalized) and a one-time pension benefit. Adjusted EPS — the Street's preferred number — was $2.30 for FY25 and is guided to ~$1.70 for FY26 [S6].
- **Cash conversion is sound** but tightening: FY25 OCF $1,742.5M vs. net income $1,152.5M = ~150% OCF/NI conversion; YTD FY26 OCF $895.6M vs. $1,346.2M prior YTD [S3] = -33% decline driven partly by litigation-receivable normalization and inventory build.
- **Reserves and contingencies are reserved but tail-risk persists.** The cooking-spray and lead-paint legacy litigation pools remain open; CAG records them as accrued but the magnitude (lead paint in particular) could escalate.
- **Auditor and accounting:** KPMG audits; no restatement history; no material weakness disclosed; the FY24 $526.5M goodwill impairment and FY26 $771.3M goodwill impairment were both routine GAAP-required marks — not earnings management.
- **Adversarial sweep clean of the "smoking-gun" category** (no short reports, no SEC investigations, no whistleblower actions identified) but multiple ongoing brand-related lawsuits and labor-relations risks (44% unionized).
- **Stance: mixed.** No restatement / audit / fraud flags; but earnings quality is fragile due to non-recurring tax + impairment volatility.

#### Implications for Thesis and Valuation
- Use **adjusted** EPS and EBITDA for the forecast (FY26 ~$1.70 adj EPS), not reported. Reported FY25 EPS of $2.40 is misleadingly high because of the abnormally low tax rate.
- Cash-flow quality is acceptable but model OCF/EBITDA conversion conservatively at ~85% (down from historical 90%+) given working-capital normalization noise and litigation accrual swings.
- Tail-risk litigation reserve should be carried as a separate scenario downside in valuation, not in the base case.

#### Objective
Test the financial-statement quality of CAG's reported numbers; perform the mandatory Adversarial Research Sweep for governance, accounting, and litigation risks that would invalidate the thesis.

#### Narrative Analysis

**Quality of EPS.** FY25 reported diluted EPS of $2.40 [S2] is a +233% jump from FY24's $0.72 — but the jump is almost entirely the absence of the FY24 $526.5M goodwill impairment and $430.2M intangible impairment. Pre-impairment "underlying" FY24 op profit was approximately $1.81B vs. FY25 of $1.46B (also ex-impairment) — so the underlying earnings trajectory was negative, not positive. The Street's adjusted EPS handle of $2.30 for FY25 better reflects the underlying trajectory.

The FY25 tax rate of 0.3% (income tax $3.7M on $1,156.2M pre-tax income [S2]) is highly unusual and reflects large discrete tax benefits (settlement of uncertain positions, intercompany restructuring). Normalized tax rate is 22–25%; backing this out, normalized FY25 EPS would have been roughly $1.80, which is consistent with the company's FY26 guide of ~$1.70 (the slight decline reflecting Chef Boyardee gone and continued category pressure).

**Quality of cash flow.** OCF generation in FY25 of $1,742.5M [S2 — derived from XBRL annual] meaningfully exceeded reported net income, a sign of healthy non-cash add-backs (depreciation $390.2M [S2], SBC $79.2M, deferred taxes). The OCF-to-net-income ratio of ~1.5× is normal and clean for CPG.

YTD FY26 OCF of $895.6M is materially below YTD FY25's $1,346.2M [S3] — about $450M lower. The 10-Q narrative attributes this to: (i) litigation-receivable / accrual normalization (net -$236M swing), (ii) inventory build, and (iii) lower pre-impairment earnings. The litigation-receivable item is non-recurring; underlying OCF deterioration is more like $150–200M, still meaningful.

**Balance-sheet impairments.** The FY26 YTD $968M aggregate impairment ($771.3M goodwill + $180M Birds Eye + $17M Earth/Smart Balance) [S3] is the largest single quality-of-earnings event. It is a GAAP-required, non-cash mark — not earnings management — but it has two material implications: (1) the company's own internal forecasts for the R&F unit had to be revised downward materially, and (2) the R&F goodwill carrying amount of $4.1B [S3] is now at "zero excess fair value over carrying" — any further negative move triggers another impairment.

**Auditor.** KPMG is the long-tenured external auditor. No restatement history; the most recent 10-K Item 9A (Controls and Procedures) reports no material weakness and a clean audit opinion [S2].

**Stock-based compensation.** SBC of $79.2M in FY25 [XBRL] is ~7% of net income and modest by CPG standards (compare with software companies at 15–30%); not a quality flag.

#### Adversarial Research Sweep (mandatory)

A directed search for short reports, accounting restatements, government investigations, whistleblower actions, and litigation that could change the thesis. Reviewed: 10-K Item 3 (Legal Proceedings), Item 9A (Controls), proxy disclosures, recent news flow, and short-interest tracker.

| Category | Finding | Status |
|----------|---------|--------|
| Short-seller report (Muddy Waters / Hindenburg / similar) | None published targeting CAG | Clean |
| SEC investigation / enforcement action | None disclosed | Clean |
| Material accounting restatement (last 10 yrs) | None | Clean |
| Material weakness in internal controls | None disclosed in FY25 10-K Item 9A | Clean |
| Auditor change | None — KPMG long-tenured | Clean |
| Lead-paint/pigment legacy litigation | Multi-decade exposure inherited from historical predecessor businesses; reserves carried on balance sheet | **Open / tail risk** |
| Cooking spray product-liability litigation | Multiple cases pending; reserved | **Open / tail risk** |
| Product recall (Armour Star, FY23) | Insurance proceeds received FY24 + partial FY25; no ongoing material impact | Resolved |
| Labor / union disputes | 44% workforce unionized; no major strike events reported FY25 | **Manageable** |
| Antitrust / FTC | No active CAG-specific case | Clean |
| Whistleblower complaint | None public | Clean |
| Major customer dispute | None disclosed | Clean |
| ESG flag / lawsuit (PFAS, BPA packaging) | Industry-wide concern; CAG not a named lead defendant | Watch |
| Insider trading / SEC Form 4 unusual pattern | CEO net 0 transactions in last 5 yrs per public trackers [S11] | Neutral signal |
| Goodwill impairment pattern (red flag for M&A discipline) | Yes — cumulative >$2.5B in impairments since FY19 | **Real but disclosed** |

The cumulative impairment record is itself a quality signal — but it is the symptom of capital-allocation decisions (the Pinnacle deal), not accounting manipulation. Conagra's accounting recognizes these losses promptly under GAAP triggers (sustained share-price decline being one); the company is not "kitchen-sinking" or smoothing.

#### Evidence and Sources

##### Reported vs Adjusted Earnings (FY24-FY26E)
| Period | Reported EPS | Adj EPS (Street) | Note |
|--------|--------------|------------------|------|
| FY23 | $1.42 | ~$2.74 | Pre-Pinnacle impairment year |
| FY24 | $0.72 | ~$2.65 | $957M impairment + divest noise |
| FY25 | $2.40 | ~$2.30 | Abnormally low tax rate inflated reported |
| FY26E (guide) | ~$1.45 (after $968M Q2 impair) | ~$1.70 [S6] | Guide lowered from prior range |

##### Cash-flow Quality
| Period | OCF ($M) | Net income ($M) | OCF / NI | Capex ($M) | FCF ($M) |
|--------|----------|-----------------|----------|-----------|----------|
| FY23 | 995.4 | 683.6 | 1.46x | 362.2 | 633 |
| FY24 | 1,177.3 | 347.2 | 3.39x | 464.4 | 713 |
| FY25 | ~1,742.5 (note) | 1,152.5 | 1.51x | ~430.0 | ~1,312 |
| YTD FY26 (39w) | 895.6 | (299.3) | n/m | 314.2 | 581 |

Note: FY25 OCF reported in the 10-K cash-flow statement; this report rebuilds via [S2]. Discrepancies with the XBRL "fy"-tagging convention noted in Step 00.

#### Assumption Register Updates
- A08 (litigation reserves adequate but tail-risk) added.

#### Tables and Calculations

##### Net Income Bridge (Quality-Adjusted)
| Item | FY25 ($M) | Adjustment |
|------|-----------|-----------|
| Reported net income | 1,152.5 | |
| − Tax-rate normalization (assume 24%) | (273) | Removes discrete tax benefit |
| + Add back intangible impairment | 72.1 | Non-cash, non-recurring |
| + Add back divestiture loss | 29.5 | Non-recurring |
| − Pension non-service income | (25.9) | Quality-of-earnings haircut |
| ≈ Underlying net income | ~955 | |
| ÷ Diluted shares (480.7M) | | |
| ≈ Underlying EPS | $1.99 | Close to Street's adj $2.30 with addbacks |

#### Open Questions and Data Gaps
- Magnitude of legacy lead-paint reserve required (range of outcomes).
- Cooking-spray total class size and per-claim economics.

#### Next-Step Dependencies
- Step 05 will use the gross-margin compression trajectory and FY26 guide as the quarterly-momentum frame.
- Step 06 will inherit the balance-sheet snapshot for solvency analysis.

#### Source Index
| Tag | Document | Section | Date | Notes |
|-----|----------|---------|------|-------|
| [S2] | CAG FY2025 10-K | Items 7/8/9A; Note 3 (impairments); Note 16 (legal) | 2026-05-28 | |
| [S3] | CAG Q3 FY26 10-Q | Notes 2/9; MD&A | 2026-05-28 | |
| [S6] | CAG Q3 FY26 earnings press release | adj EPS guide $1.70 | 2026-05-28 | |
| [S11] | secform4.com insider tracker | CEO Form 4 history | 2026-05-28 | |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/CAG/fundamental

## Navigation

- Overview: /stocks/CAG
- Financials (this page): /stocks/CAG/financials
- Thesis: /stocks/CAG/thesis
- Investment Memo: /stocks/CAG/memo
- Coverage universe: /stocks